The introduction of blood-based tests for M. tuberculosis (Mtb) infection approximately 15 years ago was a turning point for diagnosis of latent tuberculosis (TB). Interferon-gamma release assays (IGRAs), which measure Mtb antigen-specific T cell responses, include the ELISpot-based T-SPOT.TB (Oxford Immunotec, Abingdon, UK) and the ELISA-based QuantiFERON Gold In-Tube (QFT-GIT; Qiagen, Hilden, Germany)
Rational Tuberculosis infection (TBI) continues to be a striking global public health problem, incid...
Objectives: Blood-based Interferon-Gamma Release Assays (IGRA) identify Mycobacterium tuberculosis (...
BACKGROUND: The clinical utility of interferon-γ release assays (IGRAs) for diagnosis of active tube...
Development of Interferon-Gamma Release Assays (IGRAs) and implementation of their use in clinical p...
Since first presentation, Interferon γ Release Assays (IGRAs) have had basic and wide application to...
Development of Interferon-Gamma Release Assays (IGRAs) and implementation of their use in clinical p...
Development of Interferon-Gamma Release Assays (IGRAs) and implementation of their use in clinical p...
Development of Interferon-Gamma Release Assays (IGRAs) and implementation of their use in clinical p...
The interferon gamma release assays have been extensively evaluated in the diagnosis of latent tuber...
ccurate diagnosis of latent tuberculosis (TB) infection (LTBI) is scientifically challenging because...
Background: The role of interferon-gamma release assays (IGRAs) in diagnosis of active tuberculosis ...
SummaryBackgroundThe tuberculin skin test (TST) is commonly used for the diagnosis of latent tubercu...
RATIONALE: Development of diagnostic tools with improved predictive value for tuberculosis (TB) is a...
The Centers for Disease Control and Prevention recently published updated guidelines for the use of ...
This is an open-access article distributed under the terms of the Creative Commons Attribution Licen...
Rational Tuberculosis infection (TBI) continues to be a striking global public health problem, incid...
Objectives: Blood-based Interferon-Gamma Release Assays (IGRA) identify Mycobacterium tuberculosis (...
BACKGROUND: The clinical utility of interferon-γ release assays (IGRAs) for diagnosis of active tube...
Development of Interferon-Gamma Release Assays (IGRAs) and implementation of their use in clinical p...
Since first presentation, Interferon γ Release Assays (IGRAs) have had basic and wide application to...
Development of Interferon-Gamma Release Assays (IGRAs) and implementation of their use in clinical p...
Development of Interferon-Gamma Release Assays (IGRAs) and implementation of their use in clinical p...
Development of Interferon-Gamma Release Assays (IGRAs) and implementation of their use in clinical p...
The interferon gamma release assays have been extensively evaluated in the diagnosis of latent tuber...
ccurate diagnosis of latent tuberculosis (TB) infection (LTBI) is scientifically challenging because...
Background: The role of interferon-gamma release assays (IGRAs) in diagnosis of active tuberculosis ...
SummaryBackgroundThe tuberculin skin test (TST) is commonly used for the diagnosis of latent tubercu...
RATIONALE: Development of diagnostic tools with improved predictive value for tuberculosis (TB) is a...
The Centers for Disease Control and Prevention recently published updated guidelines for the use of ...
This is an open-access article distributed under the terms of the Creative Commons Attribution Licen...
Rational Tuberculosis infection (TBI) continues to be a striking global public health problem, incid...
Objectives: Blood-based Interferon-Gamma Release Assays (IGRA) identify Mycobacterium tuberculosis (...
BACKGROUND: The clinical utility of interferon-γ release assays (IGRAs) for diagnosis of active tube...